Literature DB >> 2471953

The retinoblastoma susceptibility gene product: a characteristic pattern in normal cells and abnormal expression in malignant cells.

H J Xu1, S X Hu, T Hashimoto, R Takahashi, W F Benedict.   

Abstract

Immunoprecipitation and Western immunoblotting studies were undertaken using purified high-affinity antibodies against a synthetic peptide corresponding to a portion of the deduced retinoblastoma (RB) protein. On SDS-PAGE, normal human cells showed an RB protein pattern consisting of a lower sharp band with a Mr of 110 kD and a more variable region above this band with a Mr ranging from 110 kD to 116 kD. The 110 kD band represents the unphosphorylated Rb protein whereas the broader, less well defined region is the phosphorylated RB protein in which molecular mass heterogenicity results from varying amount of phosphorylation. This pattern repeats once at a lower Mr in which a 98 kD band and 98-104 kD variable region can be visualized. This latter conformation seems to represent the unphosphorylated and phosphorylated RB protein translated from the second AUG codon of the RB mRNA. Cellular RB mRNA extracted from normal fibroblasts was translated in vitro reinforcing the usage of this second start codon. A higher ratio of phosphorylated to unphosphorylated Rb protein was seen in cells growing in log phase compared to those arrested in G1 phase. Our present studies also detected two candidates for RB-associated cellular proteins with a Mr of 124 kD and 55 kD respectively. In addition, shortened versions of RB-isoantigenic proteins were found in retinoblastoma and osteosarcoma cell lines.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2471953

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  23 in total

Review 1.  Nuclear protein phosphorylation and growth control.

Authors:  D W Meek; A J Street
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

2.  The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression.

Authors:  J A DeCaprio; Y Furukawa; F Ajchenbaum; J D Griffin; D M Livingston
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

3.  Differential retinoblastoma protein expression in neuroendocrine tumors of the lung. Potential diagnostic implications.

Authors:  P T Cagle; A K el-Naggar; H J Xu; S X Hu; W F Benedict
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

Review 4.  Role of the retinoblastoma gene in the initiation and progression of human cancer.

Authors:  W F Benedict; H J Xu; S X Hu; R Takahashi
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

5.  Hyperphosphorylation of the retinoblastoma gene product is determined by domains outside the simian virus 40 large-T-antigen-binding regions.

Authors:  P A Hamel; B L Cohen; L M Sorce; B L Gallie; R A Phillips
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

6.  Abundance and state of phosphorylation of the retinoblastoma susceptibility gene product in human colon cancer.

Authors:  R Gope; M L Gope
Journal:  Mol Cell Biochem       Date:  1992-03-25       Impact factor: 3.396

7.  The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells.

Authors:  R Takahashi; T Hashimoto; H J Xu; S X Hu; T Matsui; T Miki; H Bigo-Marshall; S A Aaronson; W F Benedict
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

8.  Further characterization of retinoblastoma gene-mediated cell growth and tumor suppression in human cancer cells.

Authors:  Y Zhou; J Li; K Xu; S X Hu; W F Benedict; H J Xu
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

9.  Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy.

Authors:  Tadeusz Majewski; Sangkyou Lee; Joon Jeong; Dong-Sup Yoon; Andrzej Kram; Mi-Sook Kim; Tomasz Tuziak; Jolanta Bondaruk; Sooyong Lee; Weon-Seo Park; Kuang S Tang; Woonbok Chung; Lanlan Shen; Saira S Ahmed; Dennis A Johnston; H Barton Grossman; Colin P Dinney; Jain-Hua Zhou; R Alan Harris; Carrie Snyder; Slawomir Filipek; Steven A Narod; Patrice Watson; Henry T Lynch; Adi Gazdar; Menashe Bar-Eli; Xifeng F Wu; David J McConkey; Keith Baggerly; Jean-Pierre Issa; William F Benedict; Steven E Scherer; Bogdan Czerniak
Journal:  Lab Invest       Date:  2008-05-05       Impact factor: 5.662

10.  Comparative study of the expression of Rb and p53 genes in human colorectal cancers, colon carcinoma cell lines and synchronized human fibroblasts.

Authors:  M L Gope; M Chun; R Gope
Journal:  Mol Cell Biochem       Date:  1991-09-18       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.